We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
10 Year Est. Return
AUM
$326M
AUM Growth
+$9.46M
Cap. Flow
-$5.18M
Cap. Flow %
-1.59%
Top 10 Hldgs %
47.09%
Holding
90
New
12
Increased
9
Reduced
29
Closed
9

Sector Composition

1 Healthcare 23.85%
2 Technology 20.89%
3 Financials 11.71%
4 Industrials 8.45%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFH icon
1
Bread Financial
BFH
$3.97B
$29.6M 9.07%
148,840
-523
-0.4% -$98.9K
AAPL icon
2
Apple
AAPL
$4.89T
$21.3M 6.53%
593,124
-2,924
-0.5% -$96.3K
ON icon
3
ON Semiconductor
ON
$34.3B
$19.2M 5.89%
1,240,770
-5,235
-0.4% -$75.9K
GILD icon
4
Gilead Sciences
GILD
$169B
$15.3M 4.7%
225,725
+12,730
+6% +$895K
MSFT icon
5
Microsoft
MSFT
$2.98T
$15.3M 4.69%
232,538
-475
-0.2% -$30.4K
CE icon
6
Celanese
CE
$5.02B
$11M 3.37%
122,320
-300
-0.2% -$26.2K
LCI
7
DELISTED
Lannett Company, Inc.
LCI
$10.9M 3.33%
121,628
-4,467
-4% -$382K
MCK icon
8
McKesson
MCK
$98.5B
$10.6M 3.25%
71,430
-337
-0.5% -$49.4K
HBI
9
DELISTED
Hanesbrands
HBI
$10.4M 3.18%
499,296
+33,420
+7% +$709K
GLD icon
10
SPDR Gold Trust
GLD
$130B
$10.1M 3.08%
84,705
-740
-0.9% -$86K
BMY icon
11
Bristol-Myers Squibb
BMY
$124B
$9.69M 2.97%
178,201
-760
-0.4% -$41.7K
UNH icon
12
UnitedHealth
UNH
$384B
$9.68M 2.97%
59,020
-75
-0.1% -$12.3K
CCJ icon
13
Cameco
CCJ
$38B
$9.65M 2.96%
871,688
+320,296
+58% +$3.65M
SAVE
14
DELISTED
Spirit Airlines, Inc.
SAVE
$9.62M 2.95%
181,205
-1,380
-0.8% -$73.8K
CELG
15
DELISTED
Celgene Corp
CELG
$9.02M 2.76%
72,493
-195
-0.3% -$23.3K
RUSHA icon
16
Rush Enterprises Class A
RUSHA
$6.19B
$8.34M 2.56%
567,027
-299,228
-35% -$4.42M
FHI icon
17
Federated Hermes
FHI
$4.53B
$7.88M 2.42%
299,221
-645
-0.2% -$17.3K
TFCFA
18
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$7.85M 2.41%
+242,290
New +$7.4M
DD icon
19
DuPont de Nemours
DD
$18.1B
$7.5M 2.3%
+46,618
New +$7.24M
MCHP icon
20
Microchip Technology
MCHP
$44.4B
$7.36M 2.26%
+199,620
New +$7.04M
BIIB icon
21
Biogen
BIIB
$30.8B
$6.99M 2.14%
25,557
+2,278
+10% +$644K
DAL icon
22
Delta Air Lines
DAL
$57B
$6.11M 1.87%
132,875
-95
-0.1% -$4.64K
GMLP
23
DELISTED
Golar LNG Partners LP
GMLP
$5.83M 1.79%
261,040
-670
-0.3% -$15.4K
GME icon
24
GameStop
GME
$9.84B
$5.82M 1.78%
1,031,856
-20,640
-2% -$126K
SLB icon
25
SLB Ltd
SLB
$70.4B
$5.71M 1.75%
73,125
-646
-0.9% -$52.8K

Similar funds

Muhlenkamp & Co's Q1 2017 Portfolio in Review

As of Q1 2017, Muhlenkamp & Co held 90 positions worth $326M, up 3% from $317M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Muhlenkamp & Co's Q1 2017 filing shows 12 new, 9 increased, 29 reduced and 9 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 242,290 shares worth $7.85M. The largest sale was WCI Communities, Inc., an estimated $9.54M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

  • Muhlenkamp & Co's largest Q1 2017 buy was Twenty-First Century Fox, Inc. Class A: 242,290 shares worth $7.85M.
  • Muhlenkamp & Co added most to Cameco in Q1 2017, an estimated $3.65M increase.
  • Muhlenkamp & Co's biggest Q1 2017 reduction was Teva Pharmaceuticals, cutting an estimated $4.55M.
  • Muhlenkamp & Co fully exited WCI Communities, Inc. in Q1 2017, selling an estimated $9.54M.
  • Muhlenkamp & Co's ten largest holdings make up 47% of its $326M portfolio in Q1 2017.
  • Muhlenkamp & Co opened 12 new positions and closed 9 in Q1 2017.
  • Muhlenkamp & Co's portfolio value rose 3% quarter-over-quarter to $326M.

Based on Muhlenkamp & Co's 13F filing for Q1 2017, filed 11 May 2017.